Enlargement or overgrowth of heart cells known as cardiomyocytes ? cardiac hypertrophy ? is a common event in many heart diseases, and occurs in an effort to restore stresses on the heart wall to normal levels.
Over the last year, it’s been rare to utter the word “stent” without at least thinking “thrombosis,” an uncommon but serious complication that’s been on the minds of interventional cardiologists and patients alike.
A novel catheter technique for patching holes in the heart may make it possible for many patients to avoid surgery altogether and others to regain enough strength to safely undergo surgical repair at a later date, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.
New data reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla., will offer clues to the fate of a new-generation drug-eluting stent that is vying for a place in the treatment of coronary artery disease.
Catheter techniques are expanding into new territory, successfully aiding in the replacement of narrowed, calcified aortic valves in patients too sick to withstand open-chest surgery.
Scientists from the Center for Applied Medical Research from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.
Employees who participated in a worksite health program improved blood pressure control by 9 percent and diabetes control by 15 percent, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
New research from UAB (University of Alabama at Birmingham) shows that the effect of diabetes on the severity of illness and risk of death for patients with heart failure is much worse in women than men. The effect is even more pronounced in older patients, according to findings published online in Heart on May 8.
Drug-eluting stents — small metal tubes used to prop open clogged arteries — have been garnering headlines. In an interview in the May issue of Mayo Clinic Women?s HealthSource, Abhiram Prasad, M.D., a Mayo Clinic cardiologist, puts recent developments in perspective.
Most women 55 years and younger who have heart attacks don’t recognize warning signs, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.